Comparator: sitagliptin phosphate

DRUG3 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Type 2 Diabetes MellitusType 2 Diabetes Mellitus (T2DM)

Phase 1

Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061)

CompletedNCT00511108

Merck Sharp & Dohme LLCType 2 Diabetes Mellitus (T2DM)

Start: 2007-07-11End: 2009-02-24Updated: 2017-05-12

Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)

CompletedNCT00704132

Merck Sharp & Dohme LLCType 2 Diabetes Mellitus (T2DM)

Start: 2007-02-14End: 2010-04-28Updated: 2017-05-12

Phase 3

A Study to Test the Safety and Efficacy of Adding Sitagliptin in Patients With Type 2 Diabetes Mellitus (MK0431-074)

CompletedNCT00813995

Merck Sharp & Dohme LLCType 2 Diabetes Mellitus

Start: 2008-12-09End: 2010-08-09Updated: 2017-05-12